IDEXX Laboratories, Inc. (BMV:IDXX)

Market Cap	914.20B
Revenue (ttm)	76.14B
Net Income (ttm)	18.59B
Shares Out	n/a
EPS (ttm)	226.52
PE Ratio	49.18
Forward PE	46.25
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	60
Open	11,558
Previous Close	11,558
Day's Range	11,558 - 11,558
52-Week Range	7,650 - 12,868
Beta	n/a
RSI	55.04
Earnings Date	Nov 3, 2025

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1983
• Employees: 11,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: IDXX

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Financial numbers in USD